Prevalence was similar across the higher risk genetic categories for HLADR-low subpopulations; however 60% of relapses in patients with MDS-like mutations had a rapid expansion of LSC-like subpopulations compared to 32% with FLT3-ITD mutated AML. The gene discussed is FLT3; the disease is myelodysplastic syndrome.